Sixty broilers (initially 1.6 kg and 35 d-old) were used to determine the effect of Bacillus subtilis C14 and RX7 strains on growth performance, blood parameter, and intestinal microbiota in response to experimental challenge with Salmonell gallinarum. Broilers were distributed to 4 treatment groups include: C1 (control group; no challenge, no B. subtilis), C2 (Salmonella-challenged group; S. gallinarum 10 8 cfu/bird), T1 (C2+supplemented with of B. subtilis C14 (1.0×10 9 cfu/g) at 0.1% in diet) and T2 (C2+supplemented with of B. subtilis RX7 (1.0×10 9 cfu/g) at 0.1% in diet). Results indicated that inclusion of B. subtilis (T1, T2) in the diet increased (P＜0.05) the weight gain and feed intake, and improved feed conversion of challenged broilers compared with no B. subtilis supplementation diet (C2). Improvements (P＜0.05) in the immunoglobulin A concentration were observed by the addition of B. subtilis compared with C2 treatment, whereas tumor necrosis factor-α was decreased (P＜0.05). Latobacillus number in small and large intestines was higher (P＜0.05) by B. subtilis additon than C2 treatment but Salmonella numbers were lower (P＜0.05). The results suggested that dietary supplementation of B. subtilis C14 and RX7 improved the growth performance, and affected the blood profiles and intestinal microbiota of broilers against S. gallinarum infection. Therefore, B. subtilis C14 and RX7 may have beneficial effects, in relieving the stress of broilers infected with S. gallinarum.
Introduction
Salmonella gallinarum (S. gallinarum) is the causative agent of fowl typhoid in avian species. Although S. gallinarum is not a serious public health concern, fowl typhoid is a severe systemic disease of poultry (Shivaprasad, 2000) , causing serious financial losses due to high mortality, septicemia, enteritis, hemolytic anemia, and reduced egg production (Christensen et al., 1992) . Although this disease has been eradicated from U. S., Canada, Australia, and most European countries, it is still a significant problem in some countries of Asia, Africa, Central America, and South America (Lee et al., 2007) . In South Korea, increased incidence of fowl typhoid has been reported since 1992. It is an endemic disease in the poultry industry (Kwon et al., 2010) .
Efforts such as vaccination and therapeutic antibiotics intervention have been made to control S. gallinarum colonization. However, antibiotics have been under strict control in animal production worldwide. Since a ban on in-feed antibiotic use was introduced in the European Union and the United States, Salmonella colonization in broiler farm has been gradually increasing in these countries (EFSA, 2007; USDA, 2007) .
Several antibacterial agents as alternatives of antibiotics have been recommended to protect chickens from Salmonella infection, including probiotics, prebiotics, bacteriophages, organic acids, enzymes, essential oils, and phytogenic additives (Patterson and Burkholder, 2003; Van Immerseel et al., 2006; Atterbury et al., 2007; Johny et al., 2010; Amerah et al., 2012) . These agents have substantiated in the last 3-4 decades. They were found to be potentially useful for preventing Salmonella and improving the performance of poultry. To reduce Salmonella contamination in broilers, Bacillus subtilis strains have been considered as reliable agent with competitive exclusion ability by reducing Salmonella load to the gut wall (La Ragione and Woodward, 2003) . In this study, B. subtilis C14 and B. subtilis RX7 strains showing superior inhibitory activity against Salmonella were tested for their potential use as probiotics for poultry. Their ability of preventing S. gallinarum infection in broiler chickens was determined in this study.
Materials and Methods
All animal trials were conducted following the animal care protocol ACUCDU 1302406 approved by the University Institutional Animal Care and Use Committee.
Isolation of Bacterial Strain for Probiotics
In this study, a total of 55 isolates were obtained from soil samples taken from Cheonan, Korea to select bacterial strains. Briefly, soil samples were serially diluted, plated onto Nutrient agar (Difco Laboratories, Detroit, MI, USA), and incubated at 37℃ for 24 h. A total of 8~9 colonies were picked from each plate. Among these isolates, two strains showing antagonistic activity against S. gallinarum ATCC 9184 were selected. They were identified as B. subtilis based on bacteria morphology and 16S rRNA gene sequencing followed by BLAST search against the NCBI (National Center for Biotechnology Information) database. The two strains were named B. subtilis C14 and B. subtilis RX7, respectively.
Experimental Design
Sixty 35-d-old male Salmonella-free Ross 308 broilers were housed in 12 battery cages (124 cm-width×64 cmlength×40 cm-height) for 7 days. These broilers were individually weighed and allocated to 4 treatments (15 birds/ treatment) with 3 replicates (5 birds/cage) per treatment based on similar body weights (1608 g). Experimental diet was corn-soybean mash meal containing 3,200 kcal/kg of metabolizable energy (ME) and 20% of crude protein (CP). The different treatment groups included unchallenged control (C1), Salmonella-challenged group (C2; S. gallinarum 10 8 cfu/bird), Salmonella-challenged group supplemented with of B. subtilis C14 (1.0×10 9 cfu/g) at 0.1% in diet (T1) and Salmonella-challenged group supplemented with of B. subtilis RX7 (1.0×10 9 cfu/g) at 0.1% in diet (T2). On day 1 of the experiment, broilers in C2, T1, and T2 groups were orally challenged through crop using a syringe with plastic injection tube. Each broiler was injected with 2 ml suspension containing approximately 10 8 cfu of S. gallinarum (ATCC 9184). S. gallinarum ATCC 9184 is a non-flagellated, gram-negative non-spore forming rod-shaped bacteria. Clinical signs of S. gallinarum in chickens include anorexia, diarrhea, dehydration, reduced immunity, and decreased body weight (Christensen et al., 1992; Lee et al., 2013) .
Growth Performance and Blood Collection
Body weight and feed intake per cage were recorded at the end of the experiment. Feed conversion was calculated based on feed intake divided by body weight gain. Blood samples of 15 broilers from each treatment were collected from jugular vein at 12 h after being challenged with S. gallinarum. For white blood cell (WBC), red blood cell (RBC), and lymphocyte profiling, approximately 3 mL of blood was collected into tubes containing K 3 EDTA (BD Vacutainer ® , Plymouth, Devon, UK). Blood was analyzed immediately after collection. To determine the levels of haptoglobin, immunoglobulin G (IgG), immunoglobulin A (IgA), immunoglobulin M (IgM), cortisol, tumor necrosis factor-α (TNF-α), Interleukin-1beta (IL-1β), Interleukin-6 (IL-6), prostaglandin E2 (PGE 2 ), and glutathione, blood samples were placed in serum separator tubes (BD Vacutainer ® ) and centrifuged at 3,000 rpm for 15 min. Serum samples were stored at −80℃ until being assayed.
Haematological and Serum Parameters
Haematological parameters such as WBC, RBC, and lymphocytes were estimated using haematology analyzer (HemaVet 850; CDC Technologies, Inc., Oxford, CT, USA). Serum haptoglobin was determined using an enzyme-linked immunosorbent assay (ELISA) kit (TP801; Tri-Delta Diagnostics, Morris Plains, NJ, USA). The levels of serum immunoglobulins (IgG, IgA and IgM) were quantified using commercial ELISA assay Kits (Bethyl Laboratories, Inc., TX, USA). Serum cortisol, TNF-α, IL-6, IL-1β, and PGE 2 were determined using ELISA kit (Lifespan Biosciences, Seattle, WA, USA). Serum glutathione levels were measured using a commercial kit from Enzo Life Sciences (Ann Arbor, MI, USA) according to the manufacturer's instructions.
Intestinal Microbial Analysis
Fresh intestinal samples from each treatment were taken at the end of the experiment. A total of 15 broilers per treatment were slaughtered and sampled after a 12-h feed with- drawal. Their large and small intestines were used to enumerate Lactobacillus, E. coli and Salmonella. Small intestinal digesta were collected from a 4-5 cm segment between the front and rear parts of the Meckel's diverticulum. Large intestinal digesta were collected from a 2-3 cm front part of the cloaca. To enumerate intestinal Salmonella, approximately 200 mg of sample was diluted 10 fold by blending them with anaerobically sterilized phosphorus buffered saline (PBS, 0.1 M, pH 7.0) and homogenized. Afterwards, a 0.1 ml sample was serially diluted 10 3~1 0 7 and spread onto sterilized flat Rogosa agar (Difco Laboratories, Detroit, MI, USA), Salmonella-Shigella (SS) agar (Difco Laboratories, Detroit, MI, USA), and MacConkey's agar (Difco Laboratories, Detroit, MI, USA) for Lactobaicllus, Salmonella, and Escherichia coli culture. Lactobacillus medium agar plates were then incubated anaerobically at 37℃ for 48 h. Salmonella and E. coli medium agar plates were incubated at 37℃ for 24 h under aerobic conditions. Colonies on each flat medium were counted using a colony counter. Results were transformed as colony-forming units (CFU) at log 10 per gram.
Statistical Analysis
The replicate was the experimental unit for growth performance. Each broiler was the experimental unit for blood profiles and intestinal microbiota counts. Tukey's test was performed to detect the significance of differences among groups using the general linear model of SAS. Orthogonal contrasts were used to test the overall effect of 2 B. subtilis supplementation (C1 vs. T1+T2 and C2 vs. T1+T2) and the individual effect of Salmonella challenge (C1 vs. C2). Variability in data was expressed as pooled SEM. Statistical significance was considered when p value was less than 0.05.
Results

Growth Performance
During the 7-day trial, body weight, weight gain, and feed intake were decreased by S. gallinarum challenge (C1 vs. C2; P＜0.001) while feed conversion was increased in the control (Table 2) . However, B. subtilis C14 and RX7 treatments significantly increased body weight, weight gain, feed intake, and feed conversion of broilers after the S. gallinarum challenge (C2 vs. T1+T2; P＜0.001).
Blood Parameters
No significant difference was observed on WBC, RBC, lymphocyte, haptoglobin, IgG, IgM, cortisol, IL-1β, IL-6, PGE2, or glutathione among all treatments (Table 3) . Serum IgA concentration was significantly (P＝0.001) higher in broilers fed with B. subtilis compared to broilers fed with C1 or C2 diet. Challenge with S. gallinarum significantly (P＝ 0.001) increased the concentration of TNF-α compared to the control. However, the concentration of TNF-α was significantly (P＝0.040) decreased in challenged groups treated with B. subtilis compared to the C2 group.
Intestinal Microflora
Broilers challenged with S. gallinarum had significantly lower number of Lactobacillus but higher numbers of E. coli and Salmonella in the small and large intestines compared to the control group (C1 vs. C2; P＜0.001, P＜0.001 and P＜ 0.001, respectively; Table 4 ). However, B. subtilis supplementation increased the number of Lactobacillus in the small and large intestines compared to C2 treatment (P＝0.009 and P＝0.003, respectively). Significantly decreased the number of Salmonella in the small and large intestines was observed in B. subtilis supplementation treatments as compared to C2 treatment (P＜0.001). However, no significant differences in the number of E. coli in the small and large intestines were determined as compared to C2 treatment (P＞0.05).
Discussion
The primary purpose of this study was to determine the effect of B. subtilis (C14 and RX7) as potential inhibitors for Salmonella infection. We found that they were effective in inhibiting the growth of S. gallinarum through agar well diffusion inhibition assay (data not shown). We then performed in vivo broiler experiment followed by experimental challenge/infection. Salmonellosis can lead to depression, diarrhea, severe body weight loss, and mortality of poultry (Vandeplas et al., Journal of Poultry Science, 54 (3) Marcq et al., 2011) . Infection with S. gallinarum decreased the weight gain compared to unchallenged broilers in this study. The decrease in weight gain might be mainly due to decreased feed intake. Our results was in consistent with previous reports on reduced weight gain and feed intake in poultry challenged with S. gallinarum (Gupta et al., 2005; Vandeplas et al., 2009; Marcq et al., 2011) . Our results also demonstrated that the addition of B. subtilis into diets could enhance the growth performance of broilers challenged with S. gallinarum. Gil de los Santos et al. (2005) and Vila et al. (2009) also observed increased weight gain and feed conversion of broiler challenged with Salmonella following supplemented with B. subtilis in the diet. In the present study, decreased body weight, feed intake, and feed conversion occurred after oral challenge with S. gallinarum. However, dietary B. subtilis mitigated these performance parameters resulting from S. gallinarum infection. We hypothesized that B. subtilis in the diet might improve the balance of intestinal microflora and increase the absorption of diet, thereby improving the growth performance of broilers.
Immune responses generated by endotoxins from invasive pathogenic strains are determined by a number of complex interactions, including factors such as immune cell interac- (Ayaz et al., 2008) . Cytokines are also important in host defense, inflammatory response, and immune-mediated diseases. Of them, TNF-α is one multifunctional cytokine that plays a major role in regulating immune responses and acute phase reactions (Akira et al., 1990) . In several studies on chicken challenged with Salmonella, improvement of humoral immune response to Salmonella infections in serum (IgG, IgM, and IgA) has been described (Pasetti et al., 2011) . It has been suggested that S. gallinarum exposure could elevate IgA levels and reflect the activation of immune system in protecting chicks against pathogen colonization. However, no significant change in serum IgA levels during the experimental period was observed in challenged groups compared to unchallenged groups in this study. The levels of IgA were higher in B. subtilis-fed groups compared to C1 or C2. Currently there is a lack of useful information regarding the role of B. subtilis in S. gallinarum infection. However, the response of broilers in T1 and T2 groups was similar to that described by Revolledo et al. (2009) , who demonstrated that a mixture of Lactobacillus, Enterococcus, and Bifidobacteria could activate the levels of total IgA in the intestinal fluid after infection with S. typhimurium. Lee et al. (2010) have also reported that dietary B. subtilis-based probiotics could reduce the clinical symptoms of coccidiosis and enhance immunity of broilers against challenges with Eimeria maxima. In addition, De Simone et al. (1993) and Miettinen et al. (1996) has reported that the addition of probiotics can increase immune cell proliferation and diminish the production of proinflammatory cytokines such as TNF-α and IL-6. In our study, the levels of IL-1β and IL-6 in broilers fed with B. subtilis were not changed. However, increased TNF-α level was observed in challenged broilers, and B. subtilis treatment might have led to decreased TNF-α in broilers challenged with S. gallinarum. Therefore, dietary B. subtilis might be able to enhance immune response and disease resistance of broilers against challenges with S. gallinarum by modulating the production of IgA and TNF-α. It has been reported that Salmonella challenge can cause higher Salmonella colonization in cecal or fecal contents (Bohez et al., 2008; Borsoi et al., 2011) but decrease Lactobacillus colonies (Audisio et al., 2000) . In agreement with these results, our study also revealed that Salmonella colonies were increased in the small and large intestines of Salmonella-challenged broilers whereas the Lactobacillus population was significantly decreased. The addition of B. subtilis to the diet decreased the Salmonella population, suggesting that B. subtilis could regulate the intestinal microflora of broilers after Salmonella infection. Our results were in agreement with the findings of other studies that resistance to pathogens and bacteria is found in broilers supplemented with B. subtilis or other probiotics (La Ragione et al., 2003; Higgins et al., 2007; Mountzouris et al., 2007; Park and Kim, 2015) . In other words, beneficial effects of probiotics seem to be exerted by suppressing the growth of enteric pathogenic bacteria while favoring the growth of beneficial bacterial species, resulting in improvement in intestinal tract health. Therefore, effect of probiotics such as improved intestinal environment and modulation of enteric immune responses might influence the proliferation of Salmonella. In addition, Bacillus subtilis C14 and RX7 strains could act as antibacterial agent against S. gallinarum, thus inhibiting Salmonella growth and improving the intestinal health.
In summary, our results suggested that dietary B. subtilis C14 and B. subtilis RX7 strains could improve the growth performance and immune function of broilers under S. gallinarum challenge situation. In addition, these two B. subtilis strains were effective in reducing intestinal Salmonella population while increasing Lactobacillus population after challenge with S. gallinarum. Therefore, B. subtilis C14 and B. subtilis RX7 strains might be able to alleviate the stress of broilers infected by S. gallinarum. They might be considered as viable alternatives of antibiotics for broiler diets.
